5 April 2019 - - US-based life science research and clinical diagnostic products company Bio-Rad Laboratories, Inc. (NYSE: BIO) has appointed Ilan Daskal as executive vice president and chief financial officer, the company said.

Daskal comes to Bio-Rad from Lumileds, where he served as chief financial officer.

He has over 25 years of experience in senior financial roles and has held several CFO positions at both public and private companies that include International Rectifier Corp. and Infineon.

Daskal holds a Masters in Finance degree from City University of New York and a BB in Accounting from Tel-Aviv College of Business in Israel.

Bio-Rad Laboratories, Inc. (NYSE: BIO) is in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets.

With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare.

Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality.

Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with more than 8,000 employees worldwide. Bio-Rad had revenues exceeding USD 2.2bn in 2018.